Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk
Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults
Wegovy costs $1,349 in the US vs. $92 in the UK. Why are weight loss drugs so pricey?
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce risks with obesity.
Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have Medicare and Medicaid.
Weight loss drugs like Wegovy, Ozempic would be covered by Medicare, Medicaid under Biden proposal
Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden administration proposed Tuesday morning.
Biden wants Medicare, Medicaid to cover pricey weight loss drugs such as Wegovy
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Medicare May Soon Cover Ozempic, Wegovy Under New Biden Proposal
If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump administration.
Biden wants drugs like Wegovy, Ozempic covered by Medicare, Medicaid
Biden proposes Medicare, Medicaid cover pricey weight-loss drugs for obese Americans
Millions of Americans could soon have access to weight-loss medications that some have called "miracle drugs."
Biden proposes expanding obesity drug coverage under Medicare and Medicaid
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid.
Biden Proposal to Cover Obesity Drugs Sets Up Quandary for Trump
The Biden administration is proposing a rule that would require the US government to cover obesity drugs for millions of Americans, teeing up a financial and political challenge for President-elect Donald Trump as he prepares to take office.
Biden proposes requiring Medicare and Medicaid to cover weight loss drugs
Under a new proposal from President Biden, weight loss drugs would be covered by Medicare and Medicaid. NBC News medical contributor Dr. Natalie Azar joins José Díaz-Balart to provide insight on who would benefit from the expanded coverage and what the approval process would look like.
Futurism on MSN17h
Woman Annoyed When She Gets on Wegovy and It Does Nothing
For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...
The Economist2d
Wegovy hits the People’s Republic, at last
But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...
Drugs like Wegovy, Ozempic would be covered by Medicare, Medicaid under Biden proposal
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
Exclusive: Thousands turn to Wegovy copies each month as FDA considers shortage status
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...
Why some people don't lose weight with Wegovy
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...
Newsday4d
Wegovy, Mounjaro: Suffolk County issues new guidelines for access to costly weight-loss drugs
The guidelines are part of a national trend by municipal governments and private firms struggling to manage ballooning costs ...
The Best Foods to Eat When Taking Wegovy for Weight Loss
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
Medicare Could Pay for Wegovy. Don’t Count On It.
The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...